These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
1108 related items for PubMed ID: 9002492
1. Adverse drug events in hospitalized patients. Excess length of stay, extra costs, and attributable mortality. Classen DC, Pestotnik SL, Evans RS, Lloyd JF, Burke JP. JAMA; ; 277(4):301-6. PubMed ID: 9002492 [Abstract] [Full Text] [Related]
2. Nosocomial bloodstream infection in critically ill patients. Excess length of stay, extra costs, and attributable mortality. Pittet D, Tarara D, Wenzel RP. JAMA; 1994 May 25; 271(20):1598-601. PubMed ID: 8182812 [Abstract] [Full Text] [Related]
3. The costs of adverse drug events in hospitalized patients. Adverse Drug Events Prevention Study Group. Bates DW, Spell N, Cullen DJ, Burdick E, Laird N, Petersen LA, Small SD, Sweitzer BJ, Leape LL. JAMA; 1994 May 25; 277(4):307-11. PubMed ID: 9002493 [Abstract] [Full Text] [Related]
4. Healthcare-associated Staphylococcus aureus bloodstream infection: length of stay, attributable mortality, and additional direct costs. Primo MG, Guilarde AO, Martelli CM, Batista LJ, Turchi MD. Braz J Infect Dis; 2012 May 25; 16(6):503-9. PubMed ID: 23158266 [Abstract] [Full Text] [Related]
5. Opioid-related adverse drug events in surgical hospitalizations: impact on costs and length of stay. Oderda GM, Said Q, Evans RS, Stoddard GJ, Lloyd J, Jackson K, Rublee D, Samore MH. Ann Pharmacother; 2007 Mar 25; 41(3):400-6. PubMed ID: 17341537 [Abstract] [Full Text] [Related]
6. Using a hospital information system to assess the effects of adverse drug events. Evans RS, Classen DC, Stevens LE, Pestotnik SL, Gardner RM, Lloyd JF, Burke JP. Proc Annu Symp Comput Appl Med Care; 1993 Mar 25; ():161-5. PubMed ID: 8130454 [Abstract] [Full Text] [Related]
7. Attributable cost of catheter-associated bloodstream infections among intensive care patients in a nonteaching hospital. Warren DK, Quadir WW, Hollenbeak CS, Elward AM, Cox MJ, Fraser VJ. Crit Care Med; 2006 Aug 25; 34(8):2084-9. PubMed ID: 16763511 [Abstract] [Full Text] [Related]
8. Costs of intravenous adverse drug events in academic and nonacademic intensive care units. Nuckols TK, Paddock SM, Bower AG, Rothschild JM, Fairbanks RJ, Carlson B, Panzer RJ, Hilborne LH. Med Care; 2008 Jan 25; 46(1):17-24. PubMed ID: 18162851 [Abstract] [Full Text] [Related]
12. Outcome and attributable cost of ventilator-associated pneumonia among intensive care unit patients in a suburban medical center. Warren DK, Shukla SJ, Olsen MA, Kollef MH, Hollenbeak CS, Cox MJ, Cohen MM, Fraser VJ. Crit Care Med; 2003 May 25; 31(5):1312-7. PubMed ID: 12771596 [Abstract] [Full Text] [Related]
15. Excess mortality, hospital stay, and cost due to candidemia: a case-control study using data from population-based candidemia surveillance. Morgan J, Meltzer MI, Plikaytis BD, Sofair AN, Huie-White S, Wilcox S, Harrison LH, Seaberg EC, Hajjeh RA, Teutsch SM. Infect Control Hosp Epidemiol; 2005 Jun 25; 26(6):540-7. PubMed ID: 16018429 [Abstract] [Full Text] [Related]
19. The attributable mortality and costs of primary nosocomial bloodstream infections in the intensive care unit. Digiovine B, Chenoweth C, Watts C, Higgins M. Am J Respir Crit Care Med; 1999 Sep 25; 160(3):976-81. PubMed ID: 10471627 [Abstract] [Full Text] [Related]
20. The risk of adverse drug events and hospital-related morbidity and mortality among older adults with potentially inappropriate medication use. Page RL, Ruscin JM. Am J Geriatr Pharmacother; 2006 Dec 25; 4(4):297-305. PubMed ID: 17296535 [Abstract] [Full Text] [Related] Page: [Next] [New Search]